OpGen, Inc. (OPGN) Financial Statements (2024 and earlier)

Company Profile

Business Address 9717 KEY WEST AVENUE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8071 - Medical Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7,44036,08013,3602,7084,5721,847
Cash and cash equivalents7,44036,08013,3602,7084,5721,847
Receivables5141,1726533,089374810
Inventory, net of allowances, customer advances and progress billings3,6464,7121,486473544533
Inventory3,6464,7121,486473544533
Other undisclosed current assets(945)(2,222)1,388397293312
Total current assets:10,65539,74316,8886,6675,7833,502
Noncurrent Assets
Inventory, Noncurrent2,3013,4721,686   
Finance lease, right-of-use asset, after accumulated amortization490450959
Operating lease, right-of-use asset1,4591,8142,0821,044
Property, plant and equipment3,4584,0123,2591311,222836
Intangible assets, net (including goodwill)7,44121,98324,6061,4181,6861,954
Goodwill  7,4538,025601601601
Intangible assets, net (excluding goodwill)7,44114,53016,5818181,0851,353
Other noncurrent assets496552780203259329
Total noncurrent assets:15,15831,92432,8633,7553,1673,118
TOTAL ASSETS:25,81371,66749,75110,4228,9506,620
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,9474,8955,4322,9593,5673,599
Employee-related liabilities1,6222,1278561,042747
Accounts payable4211,3071,8691,0561,6241,692
Accrued liabilities1,5261,9661,4371,0479021,161
Deferred revenue142 1010
Debt7,02714,5621,6641,9707981,166
Deferred revenue and credits24
Contract with customer, liability16
Other undisclosed current liabilities1,475460265   
Total current liabilities:10,59219,9177,3724,9394,3814,790
Noncurrent Liabilities
Long-term debt and lease obligation 4,85110,15720,9181,1901,098130
Long-term debt, excluding current maturities 4,8517,17619,379329660 
Capital lease obligations437130
Finance lease, liability 0447313
Liabilities, other than long-term debt2,795375269 163291
Deferred revenue and credits291
Deferred rent credit     163
Other liabilities129147157   
Operating lease, liability2,5662,9771,493547
Derivative instruments and hedges, liabilities99229113   
Other undisclosed noncurrent liabilities     08
Total noncurrent liabilities:7,64610,53321,1881,1901,261429
Total liabilities:18,23830,44928,5606,1285,6425,219
Equity
Equity, attributable to parent7,57641,21721,1914,2933,3091,401
Common stock29465251568623
Additional paid in capital281,167275,708219,129178,780165,314150,115
Accumulated other comprehensive income (loss)(796)5862,547(17)(13)(26)
Accumulated deficit(272,825)(235,542)(200,736)(174,525)(162,079)(148,710)
Total equity:7,57641,21721,1914,2933,3091,401
TOTAL LIABILITIES AND EQUITY:25,81371,66749,75110,4228,9506,620

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues2,6074,3064,2143,4992,9463,211
Revenue, net2,772
Cost of revenue(3,320)(2,848)(1,015)(2,120)(1,452)(2,133)
Cost of goods and services sold(3,320)    (2,133)
Gross profit:(712)1,4583,1991,3791,4941,078
Operating expenses(33,855)(24,731)(25,918)(13,650)(14,674)(16,344)
Operating loss:(34,567)(23,273)(22,718)(12,271)(13,180)(15,266)
Nonoperating expense(2,716)(11,489)(3,360)(175)(188)(154)
Gain (loss), foreign currency transaction, before tax380891(1,469)2(10)23
Interest and debt expense(3,256)259885(188)(191)(234)
Loss from continuing operations before equity method investments, income taxes:(40,540)(34,503)(25,193)(12,634)(13,559)(15,653)
Other undisclosed income (loss) from continuing operations before income taxes3,256(259)(885)188191234
Loss from continuing operations before income taxes:(37,283)(34,762)(26,078)(12,446)(13,368)(15,419)
Income tax expense  (44)(132)   
Loss from continuing operations:(37,283)(34,806)(26,211)(12,446)(13,368)(15,419)
Loss before gain (loss) on sale of properties:(34,806)(26,211)(12,446)(13,368)(15,419)
Net loss attributable to parent:(37,283)(34,806)(26,211)(12,446)(13,368)(15,419)
Preferred stock dividends and other adjustments  (7,167)    
Net loss available to common stockholders, diluted:(37,283)(41,972)(26,211)(12,446)(13,368)(15,419)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(37,283)(34,806)(26,211)(12,446)(13,368)(15,419)
Comprehensive loss:(37,283)(34,806)(26,211)(12,446)(13,368)(15,419)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,381)(1,962)2,564(4)13(32)
Comprehensive loss, net of tax, attributable to parent:(38,665)(36,767)(23,646)(12,451)(13,355)(15,451)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: